On November 27, 2017, the US Food and Drug Administration (FDA) released final guidance encouraging manufacturers to consider radiation safety of pediatric populations in the design of x-ray imaging ...

The Pediatric Patient Safety Program has been instrumental in improving patient safety efforts within this Children's Hospital. One indicator of this success has been the larger university hospital's ...

Pediatric populations are uniquely vulnerable to the usability and safety challenges of electronic health records (EHRs), particularly those related to medication, yet little is known about the ...

Ruxolitinib cream shows long-term safety in children with atopic dermatitis, with rare serious adverse events reported in trials. The topical formulation minimizes systemic absorption, reducing risks ...

There are racial and ethnic disparities in safety events for hospitalized children, according to a study published online Feb. 12 in Pediatrics. Kavita Parikh, M.D., from the Children's National ...

Upadacitinib induced clinical response in 75% and clinical remission in 56% of children with refractory Crohn's disease by week 8. The study involved 100 children, with most receiving a 45 mg daily ...

The Attorney General of New York, Letitia James, has called on the FDA to address safety risks associated with the widely used asthma and allergy medicine Singulair (montelukast). In a letter dated ...

Certain factors result in pediatric safety events in out-of-hospital emergent care situations based on a study published in The Journal of Pediatrics, according to News Medical. 1. Airway management ...

The oral dual endothelin receptor antagonist bosentan has been shown to improve the short- and medium-term course of adult pulmonary arterial hypertension (PAH); however, data from clinical studies in ...

Please provide your email address to receive an email when new articles are posted on . In addition to headache, pyrexia and urticaria, reported adverse events included vomiting, nausea and ...